All sponsors

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-32
RECRUITING2
READOUTS ≤12 MONTHS2
Open Jiangsu Aosaikang Pharmaceutical Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
ASKB589 Injection
NCT04632108
P1/2Active, not recruitingMalignant Solid Tumor1992025-10-31 (+38 mo)
ASKC200
NCT07742852
P2Active, not recruitingOsteoarthritis (OA) of the Knee; Pain1752026-04-28
ASK0912 for Injection
NCT07759934
P2RecruitingVentilator-associated Bacterial Pneumonia (VABP); Hospital-acquired Bacterial Pneumonia (HABP)602027-10-20
ASKC202+ Limertinib
NCT07109531
P3RecruitingLocally Advanced or Metastatic NSCLC2862027-10-31
ASKC202
NCT07897188
P3Not yet recruitingEGFR Activating Mutation; Non-Squamous Non-Small Cell Lung Cancer (NSCLC)4252030-12-30